Pavel Mykhailiuk
drug discovery
NSF Bioensaios
Sudan
Biography
Chief Scientific Officer ★ (CSO); 8 yrs designing and promoting novel building blocks for drug discovery Enamine Ltd. Karlsruhe Institute of Technology
Research Interest
Medicinal chemistry, organic synthesis, synthetic organic chemistry, drug discovery, amino acids, bioactive peptides, peptide synthesis, fluoroorganic chemistry.